These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 936280)

  • 21. Cell-mediated immunity and blocking antibodies to renal allografts.
    Hellström I; Hellström KE
    Transplant Proc; 1972 Sep; 4(3):369-71. PubMed ID: 4562764
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody-dependent cell-mediated cytotoxicity in humans. II. Energy requirement.
    Trinchieri G; De Marchi M
    J Immunol; 1975 Jul; 115(1):256-60. PubMed ID: 1151059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells.
    Ziegler HK; Henney CS
    J Immunol; 1975 Dec; 115(6):1500-4. PubMed ID: 1184963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector cell activity in antibody-mediated cell-dependent immune lympholysis. I. Normal individuals.
    Kovithavongs T; Hottman WC; Dossetor JB
    J Immunol; 1974 Oct; 113(4):1178-83. PubMed ID: 4413107
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the use of dimethyl sulfoxide in the preservation of erythrocytes and proliferating cells].
    Hoppe I
    Bibl Haematol; 1969; 32():217-21. PubMed ID: 5822800
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents.
    Gelfand EW; Morris SA; Resch K
    J Immunol; 1975 Mar; 114(3):919-24. PubMed ID: 1112985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The serological usefulness of deep-frozen lymphocytes in the cell panel].
    Bube FW; Krebs A; Siebel E; Heumann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):363-71. PubMed ID: 4139056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibody-dependent cell-mediated immune reactions--fundamentals and clinico-diagnostic relevance (author's transl)].
    Groth J; Kaden J
    Allerg Immunol (Leipz); 1980; 26(2):111-26. PubMed ID: 6449839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of spontaneous antibody-dependent cellular cytotoxicity (ADCC) and direct spontaneous lymphocyte-mediated cytotoxicity (SLMC) in patients with neoplasms].
    Degliantoni G; Mangoni L; Manna A; Fulcini M
    G Clin Med; 1981 Sep; 62(9):609-23. PubMed ID: 6976281
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans.
    Santoli D; Trinchieri G; Zmijewski CM; Koprowski H
    J Immunol; 1976 Sep; 117(3):765-70. PubMed ID: 956652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differential effect of gamma irradiation on the sensitizing and effector stages of antibody dependent lymphocyte mediated cytotoxicity.
    Pudifin DJ; Harding B; MacLennan IC
    Immunology; 1971 Nov; 21(5):853-60. PubMed ID: 5115613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A method for the cryopreservation of thrombocytes].
    Richter E; Fitzner E; Freund B; Hackensellner HA; Matthes G; Schürer M; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):725-30. PubMed ID: 6198256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and cell-mediated immune responses after donor-specific transfusion (DSBT).
    Kovithavongs T; Sharma R; Schlaut J; Burzminski D; Pazderka F; Harley F; Dossetor JB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1822-4. PubMed ID: 2652592
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
    Yust I; Wunderlich JR; Mann DL; Buell DN
    J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
    [No Abstract]   [Full Text] [Related]  

  • 39. SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.
    Bonnard GD; Chappuis M; Glauser A; Mempel W; Baumann P; Grosse-Wilde H; Albert ED
    Transplant Proc; 1973 Dec; 5(4):1679-82. PubMed ID: 4130076
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.